The illegal black market for anti-obesity medicines is growing due to high patient demand, with counterfeiters and rogue compounding pharmacies selling dangerous and untested knockoffs, while the Trump administration has a proposed rule at CMS to provide coverage for FDA-approved weight loss drugs, which would help curb this demand.
Sign up to stay connected
Get the top stories of the day around the DMV.
